Guillaume Bergthold
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Protein Degradation and Inhibitors, Chromatin Remodeling and Cancer, Multiple Myeloma Research and Treatments, Neuroblastoma Research and Treatments
Most-Cited Works
- → Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition(2014)771 cited
- → BET Bromodomain Inhibition of MYC -Amplified Medulloblastoma(2013)346 cited
- → Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database(2014)312 cited
- → Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity(2015)306 cited
- → MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism(2016)281 cited
- → Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factorMYBL1(2013)223 cited
- → Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial(2023)178 cited
- → Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)(2022)128 cited
- → Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells(2019)89 cited
- → Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation(2016)75 cited